Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
PubMed
31760574
DOI
10.1007/s10875-019-00720-6
PII: 10.1007/s10875-019-00720-6
Knihovny.cz E-zdroje
- Klíčová slova
- Blau syndrome, IFNγ, IFNγR1, MSMD, NOD2, WES, methotrexate,
- MeSH
- artritida genetika MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mutace genetika MeSH
- receptor interferonu gama MeSH
- receptory interferonů nedostatek genetika MeSH
- sarkoidóza genetika MeSH
- signální adaptorový protein Nod2 genetika MeSH
- synovitida genetika MeSH
- uveitida genetika MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
- Názvy látek
- NOD2 protein, human MeSH Prohlížeč
- receptory interferonů MeSH
- signální adaptorový protein Nod2 MeSH
Blau syndrome (BS) is an auto-inflammatory granulomatous disease that possibly involves abnormal response to interferon gamma (IFNγ) due to exaggerated nucleotide-binding oligomerization domain containing 2 (NOD2) activity. Mendelian susceptibility to mycobacterial diseases (MSMD) is an infectious granulomatous disease that is caused by impaired production of or response to IFNγ. We report a mother and daughter who are both heterozygous for NOD2c.2264C˃T variant and dominant-negative IFNGR1818del4 mutation. The 17-year-old patient displayed an altered form of BS and milder form of MSMD, whereas the 44-year-old mother was completely asymptomatic. This experiment of nature supports the notion that IFNγ is an important driver of at least some BS manifestations and that elucidation of its involvement in the disease immunopathogenesis may identify novel therapeutic targets.
Howard Hughes Medical Institute New York NY USA
Imagine Institute Paris Descartes University Paris France
Pediatric Hematology Immunology Unit Necker Hospital for Sick Children AP HP Paris France
Study Center for Primary Immunodeficiencies AP HP Necker Children Hospital Paris France
Zobrazit více v PubMed
Bioinformatics. 2009 Jul 15;25(14):1754-60 PubMed
Blood. 2005 Feb 1;105(3):1195-7 PubMed
J Leukoc Biol. 2015 Jun;97(6):1111-9 PubMed
Semin Immunol. 2014 Dec;26(6):454-70 PubMed
Nat Genet. 2001 Sep;29(1):19-20 PubMed
J Biol Chem. 2003 Mar 14;278(11):8869-72 PubMed
Nat Rev Immunol. 2014 Jan;14(1):9-23 PubMed
Ocul Immunol Inflamm. 2018;26(1):57-64 PubMed
J Inflamm Res. 2018 Feb 12;11:49-60 PubMed
J Am Acad Dermatol. 2003 May;48(5 Suppl):S99-102 PubMed
Reumatismo. 2015 Mar 31;66(4):277-84 PubMed
Gastroenterology. 2003 Apr;124(4):1001-9 PubMed
J Allergy Clin Immunol. 2012 Apr;129(4):1076-84 PubMed
Arthritis Rheum. 2009 Jan;60(1):242-50 PubMed
Immunol Rev. 2019 Jan;287(1):33-49 PubMed
Turk J Pediatr. 2016;58(5):545-549 PubMed
Pediatr Rheumatol Online J. 2014 Aug 06;12:33 PubMed
Clin Immunol. 2014 Mar;151(1):25-8 PubMed
Pediatr Dermatol. 2016 Nov;33(6):e385-e387 PubMed
N Engl J Med. 1996 Dec 26;335(26):1941-9 PubMed
Arthritis Rheum. 2009 Jun;60(6):1797-803 PubMed
Immunol Rev. 2005 Feb;203:38-47 PubMed
Pediatrics. 2001 Apr;107(4):E48 PubMed
J Allergy Clin Immunol. 2018 Jan;141(1):339-349.e11 PubMed
Sci Immunol. 2018 Dec 21;3(30): PubMed
J Pediatr. 1999 Nov;135(5):543-5 PubMed
J Immunol. 2015 Jan 1;194(1):349-57 PubMed
Blood. 1991 Dec 1;78(11):2918-22 PubMed
Nat Genet. 1999 Apr;21(4):370-8 PubMed
Rheumatology (Oxford). 2010 Jan;49(1):194-6 PubMed
Immunol Cell Biol. 2019 Apr;97(4):360-367 PubMed
PLoS Genet. 2006 Aug 18;2(8):e131 PubMed
Arthritis Rheum. 2009 Jun;60(6):1804-6 PubMed
PLoS Pathog. 2005 Nov;1(3):279-85 PubMed
Cell Physiol Biochem. 2012;30(4):953-63 PubMed
Nat Immunol. 2018 Sep;19(9):973-985 PubMed
Front Genet. 2012 Mar 15;3:35 PubMed
Cell Microbiol. 2011 Mar;13(3):402-18 PubMed
Semin Immunol. 2006 Dec;18(6):347-61 PubMed
Arthritis Rheum. 2009 Feb;60(2):611-8 PubMed
J Clin Invest. 1997 Dec 1;100(11):2658-64 PubMed
J Pathol. 1997 Jan;181(1):25-30 PubMed
Curr Opin Rheumatol. 2011 Sep;23(5):411-8 PubMed
Sci Immunol. 2018 Dec 21;3(30): PubMed
Lancet. 2002 Apr 20;359(9315):1393-401 PubMed
Rheumatol Int. 2010 Jun;30(8):1121-4 PubMed
Lancet. 2004 Dec 11-17;364(9451):2113-21 PubMed
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42 PubMed
Genome Res. 2012 Mar;22(3):568-76 PubMed
Rheumatology (Oxford). 2015 Jun;54(6):1008-16 PubMed
Bioinformatics. 2009 Aug 15;25(16):2078-9 PubMed
J Clin Invest. 2013 Oct;123(10):4142-3 PubMed
Hum Mol Genet. 2018 Nov 15;27(22):3919-3935 PubMed
J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946 PubMed
Science. 2007 Sep 14;317(5844):1522-7 PubMed
Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence